Related Experiment Videos

Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy

Bernhard Maisch1, Anette Richter, Susanne Koelsch

  • 1Department of Internal Medicine - Cardiology, UKGM GmbH and Philipps University Marburg, Baldingerstrasse, 35043, Marburg, Germany. Bermaisch@aol.com

Herz
|December 21, 2006
PubMed

Insights

Inflammatory cardiomyopathy, a form of dilated cardiomyopathy, requires specific diagnostic and treatment pathways. Early diagnosis and intervention in myocarditis cases, such as those involving cardiac sarcoid or parvovirus B19, can lead to better patient outcomes.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Inflammatory cardiomyopathy and myocarditis are acquired forms of dilated cardiomyopathy.
  • While diagnostic guidelines for myocarditis exist, specific treatment guidelines are less established, often drawing parallels with pericardial disease management.
  • Clinical pathways for accurate diagnosis and targeted treatment are becoming increasingly available.

Purpose of the Study:

  • To illustrate the importance of feasible clinical pathways for the diagnosis and treatment of inflammatory cardiomyopathy and myocarditis.
  • To highlight the impact of diagnostic approaches on patient outcomes in fulminant myocarditis.
  • To demonstrate specific treatment strategies for certain etiologies of myocarditis.

Main Methods:

  • Case study analysis of two patients with fulminant myocarditis.
  • Review of diagnostic and treatment protocols for inflammatory heart conditions.
  • Examination of parvovirus B19-positive myocarditis and its response to immunoglobulin therapy.

Main Results:

  • Successful diagnosis and treatment of cardiac sarcoidosis in one fulminant myocarditis case.
  • A fatal outcome in a case of giant cell myocarditis attributed to diagnostic nihilism.
  • Positive response to immunoglobulin treatment in active parvovirus B19-positive myocarditis.

Conclusions:

  • Feasible clinical pathways can lead to correct diagnosis and specific treatment for inflammatory cardiomyopathy and myocarditis.
  • Timely and accurate diagnosis is critical for improving outcomes in fulminant myocarditis.
  • Specific etiologies, like parvovirus B19, may benefit from targeted therapies such as immunoglobulin treatment.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...